Literature DB >> 28382779

Peri-procedural risk stratification and management of patients with Williams syndrome.

R Thomas Collins Ii1,2, Margaret G Collins3, Michael L Schmitz2,4, Justin T Hamrick4.   

Abstract

Williams syndrome (WS) is a congenital, multisystem disorder affecting the cardiovascular, connective tissue, and central nervous systems in 1 in 10 000 live births. Cardiovascular involvement is the most common cause of morbidity and mortality in patients with WS, and noninvasive and invasive procedures are common. Sudden cardiovascular collapse in patients with WS is a well-known phenomenon, especially in the peri-procedural period. Detailed guidelines for peri-procedural management of patients with WS are limited. The goal of this review is to provide thoughtful, safe and effective management strategies for the peri-procedural care of patients with WS with careful consideration of hemodynamic impacts of anesthetic strategies. In addition, an expanded risk stratification system for anesthetic administration is provided.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Williams syndrome; anesthesia; cardiac arrest; dentistry; perioperative care; surgery

Mesh:

Year:  2017        PMID: 28382779     DOI: 10.1111/chd.12447

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  3 in total

Review 1.  Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes.

Authors:  Mark W Russell; Wendy K Chung; Jonathan R Kaltman; Thomas A Miller
Journal:  J Am Heart Assoc       Date:  2018-03-09       Impact factor: 5.501

2.  Cardiac arrest after induction of anesthesia in a 2-month-old infant with undiagnosed Williams syndrome.

Authors:  Julie D Dunlap; Morton C Green; Aali M Shah; Brandon T Kibby; Deborah F Billmire
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun

Review 3.  Williams syndrome.

Authors:  Beth A Kozel; Boaz Barak; Chong Ae Kim; Carolyn B Mervis; Lucy R Osborne; Melanie Porter; Barbara R Pober
Journal:  Nat Rev Dis Primers       Date:  2021-06-17       Impact factor: 65.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.